The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2009

Filed:

Jul. 25, 2005
Applicants:

David M. Goldenberg, Mendham, NJ (US);

Zhengxing Qu, Warren, NJ (US);

Eva Horak, West Orange, NJ (US);

Ivan D. Horak, West Orange, NJ (US);

Chien Hsing Chang, Dowinngtown, PA (US);

Edmund A. Rossi, Nutley, NJ (US);

Jeng-dar Yang, Bedminster, NJ (US);

Inventors:

David M. Goldenberg, Mendham, NJ (US);

Zhengxing Qu, Warren, NJ (US);

Eva Horak, West Orange, NJ (US);

Ivan D. Horak, West Orange, NJ (US);

Chien Hsing Chang, Dowinngtown, PA (US);

Edmund A. Rossi, Nutley, NJ (US);

Jeng-Dar Yang, Bedminster, NJ (US);

Assignee:

Immunomedics, Inc., Morris Plains, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/10 (2006.01); C12N 5/16 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed herein are compositions and methods for increasing the longevity of a cell culture and permitting the increased production of proteins, preferably recombinant proteins, such as antibodies, peptides, enzymes, growth factors, interleukins, interferons, hormones, and vaccines. By transfecting cells in culture with an apoptosis-inhibiting gene or vector, cells in culture can survive longer, resulting in extension of the state and yield of protein biosynthesis. Expression of the apoptosis-inhibitor within the cells, because it does not kill the cells, allows the cells, or an increased fraction thereof, to be maintained in culture for longer periods. This invention then allows for controlled, enhanced protein production of cell lines for commercial and research uses, particularly the enhanced production of growth factors, interferons, interleukins, hormones, enzymes, and monoclonal antibodies, and the like. The method preferentially involves eukaryotic cells in culture, and more advantageously mammalian cells in culture.


Find Patent Forward Citations

Loading…